Takeda Pharmaceutical strengthens medical system to meet patients' needs for plasma-fractionated formulations

　Takeda Pharmaceutical Co., Ltd. (hereafter, “Takeda Pharmaceuticals”) and the United Nations Institute for Training and Research (hereafter, “UNITAR”), an active member of the United Nations Global Compact, have recently announced a new joint initiative focused on strengthening healthcare systems in each country that meet patients' needs for plasma and plasma-fractionated formulation businesses as part of their partnership I did it, so I'll let you know. The initiative was launched by UNITAR's expertise in training and education, which finds innovative solutions to global challenges, and experience in our rare disease and plasma business ecosystem.